Several reports have suggested a possible association between the interleukin (IL)-8-251A/T single-nucleotide polymorphism (SNP) and the susceptibility to coronary artery disease (CAD). Due to inconclusive results of the studies so far, we conducted a metaanalysis to systematically summarize the studies on the association between this SNP and CAD risk. A systematic literature search identified 9 case-control studies (3752 cases and 4219 controls) on the IL-8-251A/T polymorphism. We observed a significant association between different genetic forms of À251A/T SNP and CAD risk, like the allele model (A vs T: odds ratio [OR] 1.14, 95% confidence interval [CI] 1.02-1.27, P = .02), dominant model (AA + AT vs TT: OR 1.20, 95% CI 1.01-1.43, P = .042), recessive model (AA vs AT + TT: OR 1.15, 95% CI 1.03-1.27, P = .01), and homozygous model (AA vs TT: OR 1.26, 95% CI 1.01-1.56, P = .037), whereas the heterozygote model did not show any significant association (AT vs TT: OR 1.16, 95% CI 0.98-1.38, P = .091). Furthermore, significant heterogeneity was observed among studies in terms of all genetic models, except the recessive model. Analysis of the ethnic subgroups revealed a significantly higher risk of CAD in the East Asian population carrying this SNP, and the heterogeneity among the studies regarding the East Asian population was decreased after subgroup analysis. The results of this meta-analysis suggest that the IL-8-251A/T SNP may increase the risk of CAD, especially in people of East Asian ethnicity. Further large-scale, multicenter epidemiological studies are warranted to validate this finding.
Introduction
Coronary artery disease (CAD), 1 of the most common heart diseases, is a group of clinical manifestations including stable and unstable angina, myocardial infarction, and sudden coronary death. [1] It is associated with high mortality and morbidity in both developed and developing countries. [2] CAD develops over a long period of time and involves several lifestyle factors, including diet, hypertension, hypercholesterolemia, diabetes, obesity, and lack of physical activity. [3] [4] [5] [6] Nevertheless, only a small percentage of individuals with these high-risk factors develop CAD, suggesting a hereditary basis of CAD pathology.
The interleukin 8 (IL-8) gene is located on chromosome 4q13-q21, and comprises of 4 exons, 3 introns, and a proximal promoter region. [7] IL-8 plays an important role in regulating both inflammatory and immune processes. [7, 8] Since its discovery in the late 1980s, IL-8 has been shown to participate in all stages of atherosclerosis, from vascular inflammation to cardiac remodeling after myocardial infarction (MI), [9] suggesting an association between IL-8 gene and CAD risk. Several studies have examined the association between 2 common IL-8 gene polymorphisms, À251A/T (rs4073) and 781C/T (rs2227306), and the risk of CAD. [10, 11] The polymorphism at the À251 position of the promoter region of the IL-8 gene affects its transcriptional activity, and the homozygous À251A allele is correlated with increased expression. [12, 13] To date, many studies had assessed the association between the IL-8-251A/T single-nucleotide polymorphism (SNP) and CAD risk, but the results have been inconclusive. [10, 11, [14] [15] [16] [17] [18] [19] [20] Therefore, we conducted a meta-analysis on 9 published case-control studies examining this association.
Methods

Search strategy and eligibility of relevant studies
The PubMed database was searched for articles published from 1948 to present, and EMBASE from 1974 to present (last search June 20, 2018). Combinations of the following phrases were used: "coronary artery disease or coronary heart disease or cardiovascular diseases," "polymorphism or variation or variant or mutation," and "Interleukin 8 or IL-8 or rs4073." To retrieve the most eligible studies, we evaluated all articles and manually searched their references. The inclusion criteria were as follows: English-language papers and human-associated studies; casecontrol studies; evaluating the association between À251A/T SNP and risk of CAD; containing useful genotypic frequency. The study was reviewed and approved by the Ethics Committee of Wuxi People's Hospital Affiliated to Nanjing Medical University.
Study selection
The literature search was conducted by 1 investigator (Y.W.). Two researchers (Y.W. and W.W.) independently selected the studies for inclusion according to eligibility criteria. Disagreements between reviewers were resolved by consensus; if the disagreement pertained, a third author (R.X.W.) made the final decision.
Data extraction
Two investigators extracted the data independently and reached consensus on all items. For each of the eligible publications, the following data were extracted: first author's surname, year of publication, country of study population, ethnicity, total number of cases and controls, genotyping methods and matching criteria, and the numbers of all individuals with the TT, TA, and AA genotypes.
Assessment of study quality
The quality of the included studies was assessed using the Newcastle-Ottawa Quality Assessment Scale for case-control studies. A study can be given a maximum of 1 star for each numbered item within the selection and exposure categories. A maximum of 2 stars can be awarded for comparability. The total quality scores ranged from 0 to 9 stars.
Statistical analysis
The statistical analyses were performed with the STATA software version 12.0 (STATA Corp., College Station, TX). To measure the strengths of the genetic associations of the IL-8-251A/T SNP with CAD risk, the pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A chi-square test was performed to determine whether the genotypic frequencies deviated from the Hardy-Weinberg equilibrium (HWE). The heterogeneity among studies was analyzed using the Q statistic test. P values less than .10 were considered statistically significant. [21] If significant heterogeneity was observed, the DerSimonian-Laird method was used to evaluate the pooled ORs (95% CIs) in random-effects model. If no significant heterogeneity was observed, the MantelHaenszel test was used to calculate the pooled ORs (95% CIs) in fixed-effects models. [22] To explore the effect of heterogeneity among the studies, subgroup analyses were performed. Sensitivity analysis was performed by omitting each study to assess the quality and consistency of the results. We also performed Egger test to examine publication bias, and P < .05 was considered statistically significant. [23] 3. Results
Characteristics of studies
A total of 103 published articles were obtained by keywordrelated and manual search. Figure 1 illustrates the process of inclusion and exclusion of associated studies, which finally identified 9 articles including a total of 3752 cases and 4219 controls suitable for our meta-analysis. [10, 11, [14] [15] [16] [17] [18] [19] [20] For 2 studies [18, 19] that involved 2 stage groups, each group was analyzed separately. The quality scores of all of the included studies were greater than 5 stars. The characteristics of eligible studies are summarized in Table 1 . Five studies were on East Asian populations and 4 on Caucasians. All studies used blood samples for DNA extraction. Polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) assay was used in 6 studies, 2 studies used TaqMan (Applied Biosystems, Foster City, CA) method, and 1 study used Matrix Adsorbed Laser Desorption-Ionisation-Time of Flight (MALDI-TOF) to detect the genotypes. CAD was confirmed by coronary angiography in all studies. In addition, 8 studies were hospitalbased and 1 was population-based. [11] The distribution of genotypes among the controls of the studies was in agreement with HWE in 6 studies. [10, 15, 17] The genotypic frequencies of the À251A/T SNP in the studies included in the meta-analysis are listed in Table 2 .
Association between the IL-8-251A/T polymorphism and CAD risk
As shown in Table 3 , the pooled results indicate a significant association between IL-8-251A/T SNP and CAD risk in most genetic models: allele model (A vs T: OR 1.14, 95% CI 1.02-1.27, P = .02) (Fig. 2) ; dominant model (AA + AT vs TT: OR 1.20, 95% CI 1.01-1.43, P = .042); recessive model (AA vs AT + TT: OR 1.15, 95% CI 1.03-1.27, P = .01); and homozygous genetic model (AA vs TT: OR 1.26, 95% CI 1.01-1.56, P = .037). The heterozygous model (AT vs TT) did not show any significant association with CAD risk (OR 1.16, 95% CI 0.98-1.38, P = .091).
Publication bias
Begg funnel plot and Egger test were used to assess the publication bias. As shown in Fig. 3 , the funnel plots did not reveal any obvious asymmetry in all genotypes in overall population. Neither test showed any statistical evidence for publication bias in our meta-analysis (P > .05).
Heterogeneity and sensitivity analyses
Substantial heterogeneity was observed among studies for all genetic models (AA + AT vs TT: I 2 = 62.6%, P = .006; AT vs TT: I 2 = 55.9%, P = .020; AA vs TT: I 2 = 61.0%, P = .009; A vs T: I 2 = 61.3%, P = .008), except AA vs AT + TT model (I 2 = 28.7%, P = .190) ( Table 3) . Next, we assessed the source of heterogeneity in all genetic models by comparing the ethnicities of the study groups. The heterogeneity was significantly decreased in the East Asian population after subgroup analysis, whereas significant heterogeneity was observed among Caucasians (Table 3) .
Sensitivity analyses showed that the study by Velásquez et al [11] was the major contributor of heterogeneity for the allele model (I 2 = 61.3%, P = .008). After excluding this study, the heterogeneity was significantly reduced (I 2 = 21.1%, P = .262) ( Table 4) . As expected, similar results were observed for other genetic models (ie, AT vs TT and AA vs TT). However, the statistical significance of the results was not altered when any single study was omitted, confirming the stability of the results. Wu 
Discussion
Coronary artery disease is caused by a combination of genetic and environmental factors. The individual differences in CAD susceptibility, despite similar environmental risk factors, [24] suggests a vital role of gene variants in the pathogenesis of CAD. Therefore, increasing numbers of studies in recent times have focused on the association of the SNPs of genes related to CAD and its pathogenesis. [25, 26] Genome-wide association study has helped identify gene variants in different ethnic populations that are associated with increased susceptibility to CAD. Mutations in the CDKN2A/2B/ANRIL gene cluster, PHACTR1, NHGRI, and KCNE2, have been identified as the risk factors of CAD. [27] Numerous studies have found an association between the IL-8-251A/T SNP and CAD risk. Four studies [10, 11, 14, 19] have indicated a significant association between the À251A/T SNP and CAD, whereas the other studies showed no association. [15] [16] [17] [18] 20] Therefore, we performed a comprehensive meta-analysis with the aim of clarifying whether there is a significant association of the IL-8-251A/T SNP (rs4073) with CAD susceptibility. To the best of our knowledge, this is the first meta-analysis that systematically explores this association.
Rus et al [28] hypothesized that IL-8 expression is induced by complement activation, which may contribute to the increased IL-8 levels seen in atherosclerotic vessel walls. Moreover, this cytokine is involved in the inflammatory response during the initiation and progression of atherosclerosis. IL-8 production remains elevated for an extended period during acute inflammation, whereas other inflammatory cytokines are cleared within a few hours. [29, 30] Liu et al [31] reported that IL-8 helps recruit T lymphocytes and smooth muscle cells to the subendothelial space and has a major role in the formation of atherosclerotic lesions, whereas Nair et al [32] found that IL-8 expression was a predictor of cardiovascular risk. The À251A/T SNP lies in the promoter region of the IL-8 gene, and therefore affects its transcriptional activity. Homozygosity of the À251A allele has been associated with increased expression of the IL-8 gene. [12, 13] In fact, all genetic states of the À251A/T SNP may play a role in the pathogenesis of atherosclerosis by influencing the transcriptional activity and the expression of the IL-8 gene, and thus influence CAD risk.
In this meta-analysis, 9 studies with a total of 3752 cases and 4219 controls on the association between the potentially functional polymorphisms of IL-8-251A/T and CAD risk were included. Pooled results of the overall population showed that there was significant association between most genetic states of À251A/T SNP and CAD risk as follows: allele model (A vs T: OR 1.14, 95% CI 1.02-1.27, P = .02); dominant model (AA + AT vs Table 2 Genotype frequencies in the studies included in the meta-analysis.
Genotype frequency (n)
Cases Controls   Reference  Year  TT  TA  AA  A  T  TT  TA  AA  A  T Zhang et al [14] 2017 47  101  69  239  195  80  108  57  222 268 Yang et al [15] Table 3 Stratified meta-analysis of the effect of À251A/T polymorphism of IL-8 gene on risk for CAD. . This is the first study to report these findings.
Heterogeneity is a key factor in determining the reliability of meta-analysis results. In the overall population, significant heterogeneity was observed in almost all genetic models: A vs T: x 2 = 20.67 (P = .008), AA + AT vs TT: x 2 = 21.41 (P = .006), AT vs TT: x 2 = 18.14 (P = .020), AA vs TT: x 2 = 20.50 (P = .009). Only the AA vs AT + TT model showed no heterogeneity (x 2 = 11.22, P = .190). To find the source of heterogeneity, we conducted a subgroup analysis by ethnicity. As shown in Table 3 , there was a significant association of most genetic models in the East Asian ethnic subgroup, whereas no significant association was found in the Caucasian group. Furthermore, no significant heterogeneity was observed in the East Asian population after subgroup analysis. These results suggest that ethnicity might be the major source of heterogeneity. In addition to ethnicity, sensitivity analysis suggested that the study by Velásquez et al, [11] which focussed on the Caucasian group, was the major contributor of heterogeneity. However, the overall results did not show quantitative changes when excluding any study, thereby underscoring the stability and reliability of this metaanalysis. In addition, publication bias is another important factor in evaluating the reliability of results, and along with the study quality is vital for conducting a meta-analysis. Publication bias was analyzed using Begg funnel plots and Egger test in our study. No significant publication bias was detected, further indicating the reliability of our results.
There are some limitations of this meta-analysis. First, selection bias could have influenced the results because the genotypic distribution of this SNP among control subjects deviated from the HWE in 3 studies, [10, 15, 17] and most of the controls were hospitalized patients who may not be representative of the general population. Second, the studies included in the analysis used different genotyping methods with different quality control issues, which may also influence the results. Third, we only included the published studies in the meta-analysis, and it is possible that we might have missed some related unpublished studies which would have met the inclusion criteria. Apart from that, the addition of some other research, such as the cohort study, can increase the credibility of our meta-analysis results. But, we did not find any other study designs to explore this association of the interleukin-8-251A/T polymorphism and CAD risk by searching for keywords. Finally, the number of cases and controls in the included studies were relatively low (data shown in Table 1 ), and large-scale multicenter studies are warranted to further validate our results.
Conclusions
In conclusion, our meta-analysis provides the first unambiguous indication that IL-8-251A/T SNP is a risk factor for CAD susceptibility in the overall population, especially in the East Asian ethnic groups. Further large-scale multicenter epidemiological studies are warranted to validate this finding. Table 4 Sensitivity analysis of IL-8-251A/T in allele model.
Study omitted
OR (95% CI) P for heterogeneity I 2 Zhang et al [14] 1.11 (1.00-1.23) .023 57.0% Yang et al [15] 1.14 (1.01-1.29)
.004 66.1% Ren and She [16] 1.13 (1.00-1.28)
.005 65.6% Wang et al [17] 1.14 (1.01-1.29)
.004 66.1% Velásquez et al [11] 1.21 (1.12-1.30) .262 21.1% Zhang et al [19] 1.07 (1.00- 1.15) .081 44.8% La Manna et al [18] 1. 16 (1.03-1.30) .007 64.0% Vogiatzi et al [20] 1.14 (1.01-1.28)
.004 66.1% Vogiatzi et al [10] 1.15 (1.02-1.29) .005 65.8% CI = confidence interval, OR = odds ratio. 
